3DPOD Episode 191: Amy Alexander, 3D Printing at the Mayo Clinic

RAPID

Share this Article

Amy Alexander leads the 3D printing initiatives at the Mayo Clinic. You’ll be astounded by the ambitious plans this hospital has for additive manufacturing. In this episode of the 3DPOD, Amy discusses the Mayo Clinic’s multi-year strategy to utilize powder bed fusion for printing metal implants, instruments, and devices in-house. Additionally, Amy elaborates on how her team is applying Additive Manufacturing within the hospital. In particular areas, like new device design, the team is indeed undertaking innovative activities. This is essential reading for anyone interested in the intersection of 3D printing and healthcare.

Share this Article


Recent News

Origin Shareholders Escalate Legal Battle Against Stratasys Over Earn-Out Payments

Former 3D Systems’ Exec Launches GenesisTissue for Bioprinting



Categories

3D Design

3D Printed Art

3D Printed Food

3D Printed Guns


You May Also Like

Stanford’s Dr. Skylar-Scott Breaks Down the Timeline for Fully Bioprinted Organs

Bioprinting has transitioned from an ambitious idea to a field making steady progress toward creating functional tissues and vascularized structures, offering a glimpse into the future of regenerative medicine. Against...

Can 3D Printing with Captured Carbon Help Address Climate Change?

It sounds almost too good to be true, but a recent study published in Nature Communications describes a potentially groundbreaking process where carbon dioxide (CO2) is converted into 3D-printed carbon...

Featured

American Axle & Manufacturing Acquires GKN Powder Metallurgy and GKN Automotive for $1.44B

American Axle & Manufacturing (AAM), a publicly listed supplier of automotive driveline and drivetrain components headquartered in Detroit, has acquired Dowlais Group plc, the parent company of GKN Automotive and...

Stanford’s $250 Bioprinter Makes Bioprinting Accessible to All

Bioprinting has long been praised as a groundbreaking tool for advancing regenerative medicine, drug testing, and tissue engineering. But despite its immense potential, the high cost of bioprinters has kept...